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ABSTRACT
Introduction Mapping the current body of evidence 
including what is missing helps provide a better 
understanding of what research is available, ongoing and 
needed and should be prioritised. Identifying research gaps 
can inform the design and conduct of health research by 
providing additional context information about the body of 
evidence in a given topic area. Despite the commonly used 
term ‘research gap’ in scientific literature, little is written 
on how to find a ‘research gap’ in the first place. Moreover, 
there is no clear methodological guidance to identify and 
display gaps.
Objective This study aimed to explore how key 
stakeholders define research gaps and characterise 
methods/practices used to identify and display gaps in 
health research to further advance efforts in this area.
Design This was an exploratory qualitative study using 
semistructured in- depth interviews. The study sample 
included the following stakeholder groups: researchers, 
funders, healthcare providers, patients/public and policy- 
makers. Interview transcripts were subjected to thematic 
analysis.
Results Among the 20 interviews conducted (20 
participants), a variety of research gap definitions were 
expressed (ie, five main themes, including gaps in 
information, knowledge/evidence gaps, uncertainties, 
quality and patient perspective). We identified three 
main themes for methods used to identify gaps (primary, 
secondary and both primary and secondary) and finally six 
main themes for the methods to display gaps (forest plots, 
diagrams/illustrations, evidence maps, mega maps, 3IE 
gap maps and info graphics).
Conclusion This study provides insights into issues 
related to defining research gaps and methods used to 
identify and display gaps in health research from the 
perspectives of key stakeholders involved in the process. 
Findings will be used to inform methodological guidance 
on identifying research gaps.
BACKGROUND
Identifying research gaps can help inform the 
design and conduct of health research, prac-
tice and policies by providing a better under-
standing of the current body of evidence. 
Healthcare decisions for individual patients, 
public health policies and clinical guidelines 
should be informed by the best available 
research while taking into account research 
gaps.
The identification of research gaps has 
no well- defined process, although research 
gaps serve as the basis in developing a new 
research question and informing future 
research, healthcare delivery and health poli-
cies. In addition, research gaps in healthcare 
do not necessarily align directly with research 
needs. Hence, research gaps are critical in 
that knowledge gaps substantially inhibit the 
decision- making ability of stakeholders such 
as patients, healthcare providers and policy- 
makers, thus creating a need to fill the knowl-
edge gap.1
Moreover, identifying and character-
ising research gaps often highlight multiple 
competing gaps that are worthwhile to be 
explored.1 Initiatives such as the James Lind 
Alliance (JLA), UK Database of Uncertainties 
about the Effects of Treatments, Cochrane 
Agenda and Priority Setting Methods Group, 
and Evidence- based Research Network are 
Strengths and limitations of this study
 ► This study used qualitative methodology that pro-
vided an in- depth understanding of key stakehold-
ers’ perspectives and experiences in identifying, 
describing and displaying gaps in health research.
 ► The study benefited from having a variety of dif-
ferent stakeholders participating in semistructured 
interviews, which provided a wider scope of per-
spectives and experiences in identifying, describing 
and displaying gaps in health research.
 ► This study could have benefited from involving pa-
tient/public perspectives to inform the design of the 
study to improve the importance and relevance of 
the findings for this population.
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some examples of existing efforts to identify and priori-
tise research gaps in health.2
The term ‘research gap’ is not well defined, and its 
meaning can differ depending on the researcher and 
research context. A recent scoping review of methods used 
to identify, prioritise and display gaps in health research 
reported 12 different definitions related to gaps in health 
research, each describing research gaps differently.2 This 
finding shows the ambiguity of the term ‘research gap’ 
and the different practices it may relate to.
As a basis for further exploring and understanding 
‘research gaps’, we start from the definition given by the 
National Collaborating Centre for Methods and Tools in 
Canada based on the work by Robinson et al, whereby a 
research gap is defined as a topic or area for which missing 
or insufficient information limits the ability to reach a 
conclusion for a question.3 Given the different meanings 
and definitions of research gaps identified in the scoping 
review,2 we considered it important to further explore key 
stakeholders’ perspectives to better understand the topic 
area. Clearly defining the type of research gap can help 
determine how to better identify, characterise, prioritise 
and address research gaps.
Different methods for identifying research gaps 
reported include scoping reviews and umbrella reviews 
for mapping and summarising evidence. These methods 
have an explicit aim of identifying research gaps in a 
broad area compared with systematic reviews, which focus 
on answering a specific research question.4–8 Further-
more, investigating experiences with practices/methods 
used to identify research gaps can inform explicit meth-
odological approaches in identifying and describing 
research gaps. This investigation can enhance practices 
of different stakeholder groups (ie, health professionals, 
health commissioners, researchers, patients/public and 
decision- makers) when addressing areas of uncertainty 
within the research problem and topic area.9
The specific objectives of the study were to (1) investi-
gate key stakeholders’ knowledge and perceptions of and 
experiences with defining research gaps and (2) char-
acterise methods/practices used to identify and display 
gaps in health research.
METHODS AND ANALYSIS
Qualitative study design
We conducted an exploratory qualitative study using semi-
structured interviews. This method was selected to provide 
an in- depth understanding of key stakeholders’ perspec-
tives, experiences and practices in defining, identifying 
and displaying research gaps. This method also ensured 
that we explored key stakeholders’ understanding and 
practices related to identifying research gaps through a 
variety of lenses from different stakeholder groups. In 
turn, this process provided multiple facets of research gap 
definitions and methodological practices to identify and 
display gaps.10
Study sample and recruitment
We used purposive sampling to ensure that the perspec-
tives of all identified stakeholder groups were repre-
sented. Purposive sampling is widely used in qualitative 
research to identify and select information- rich cases. 
The study sample included the following stakeholder 
groups: researchers, funders, healthcare providers, 
patients/public and policy- makers. The stakeholder 
groups were determined according to the findings of a 
previously conducted scoping review2 and organised into 
three main categories focusing on the use of evidence to 
inform health policy, health practice and health research 
(table 1). A detailed description of participant categories 
was given in the previously published study protocol.11 
Study participants were recruited via contacts and organi-
sations identified in the scoping review, relevant scientific 
publications, existing professional networks (eg, H2020 
International Training Network ‘Methods in Research on 
Research’) and contacts from conference attendance (eg, 
Evidence Live and Cochrane Colloquium).
The main inclusion criteria for the study were as follows:
1. Adults aged ≥18 years (researchers, funders, health-
care providers, patients/public and policy- makers).
2. Experience with the use of evidence to inform health 
decisions/choices, policy, practice or research.
3. Ability to converse in English.
4. Consent for research.
The sample size for qualitative studies usually depends 
on the point when data saturation is reached (ie, the point 
when new data do not add to a better understanding of 
the studied phenomenon but rather repeat what was 
previously expressed12). Considering that the point of 
saturation cannot be specified in advance, we planned 
to conduct between 14 and 28 interviews, owing to usual 
points of data saturation reported in qualitative studies.11 
The point of data saturation was determined based on the 
seven parameters identified by Hennink et al,13 14 including 
the study purpose, population, sampling strategy, data 
quality, type of codes, code book and saturation goal, and 
focus retrieved from the study. These parameters were 
Table 1 Participant characteristics (n=20)
Category No. (% of total)
Researcher 9 (45)
  Methodologist 5 (25)
  Data visualisation 3 (15)
  PhD student 1 (5)
Health practitioner 6 (30)
  Healthcare provider 5 (25)
  Public health professional 1 (5)
Oversight bodies 3 (15)
  Health policy- maker 2 (10)
  Funding body 1 (5)
Patients/public 2 (10)
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discussed throughout the study primarily between the 
lead researcher (LN) and the senior researcher (DH).
Data collection and recording
Semistructured interviews were used for this study. The 
main reason for selecting semi- structured interviews was 
to allow for specific areas to be addressed while giving 
the interviewees the opportunity to reflect on their expe-
riences and perspectives related to defining, identifying 
and presenting research gaps that are relevant to them 
and that may not have been explored or anticipated by 
the researcher(s).15
The guide was developed by focusing on exploring 
key stakeholders’ perspectives and experiences with the 
following key areas:
1. Participant background information.
2. Definitions of research gaps.
3. Knowledge and perceptions of and experiences with 
methods/practices used to identify and display gaps in 
health research to inform further health policy, prac-
tice and research.
These three categories were developed with informa-
tion from the scoping review to guide the questions. The 
interview topic guide was piloted before data collection. 
It was also adapted according to key stakeholder groups 
to ensure that it was meaningful to their background and 
to gather more relevant information based on their expe-
riences and knowledge.16
The semistructured interview guide contained two 
levels of questions: main themes and follow‐up questions. 
The main themes covered the general content of the 
research gaps aimed at encouraging participants to speak 
freely about their perceptions, experiences and practices. 
The follow- up questions were used as prompts and probes 
aiming to follow respondents’ answers and to investigate 
the issues raised more in depth. The interview guide 
covered the main topics of the study, providing a focused 
structure for the discussion during the interview.17
We conducted in- person, telephone and teleconference 
interviews. In- person interviews were conducted with 
participants residing or reachable in London, UK, and 
other participants were interviewed via telephone or tele-
conference (for the interview guide for both in- person 
and teleconference interviews, see online supplemental 
appendix).
All interviews were digitally recorded, transcribed 
verbatim and anonymised. The lead researcher (LN) 
transcribed two interviews to help inform the analytical 
process, and the other audio files were transcribed by 
a professional transcription agency licensed from the 
University of Liverpool.
Data analysis
We used analytical categories to describe and explain defi-
nitions, experiences and practices reported among the 
groups of participants. All data relevant to each category 
(defining research gaps, experiences with methods/prac-
tices used to identify and display gaps in health research) 
were identified and examined to ensure that each data 
item was checked accordingly.
Our approach was based on the thematic analysis 
outlined by Braun and Clarke.18 The steps included the 
following: (1) transcription and checking transcripts with 
recordings for accuracy, (2) open coding from interview 
responses performed by two researchers independently 
(LN and DH), (3) agreement of initial codes discussed 
among the researchers and an initial codebook devel-
oped, (4) developing the code structure used for analysing 
the remaining responses with openness that included 
new codes and refined existing ones and (5) themes and 
subthemes identified from the final code structure and 
their relationships presented.18
The initial coding framework for our analysis started 
from broad categories identified in the previous scoping 
review with which the interviews were structured. Within 
these broad categories (ie, defining research gaps, experi-
ences with methods/practices used to identify and display 
gaps in health research), analytical categories were induc-
tively derived from the data. In this sense, our approach 
includes both top- down and bottom- up development of 
analytical categories and themes.
QSR International’s NVivo V.12 qualitative data analysis 
software was used for data management and analysis.
Ensuring study quality
To further ensure rigour and trustworthiness, the study 
was guided by Lincoln and Guba ’s concepts for defining 
and investigating quality in qualitative research that can 
be considered parallel to quantitative research concepts 
of validity and reliability.13 19 20 The concepts include cred-
ibility, transferability, dependability, confirmability, audit 
trails and reflexivity. They are interrelated, and thinking 
through them from the onset and incorporating them 
into a study improve the study’s rigour.
The main researcher’s (LN) past experience as a Public 
Health Advisor at a National Institute of Public Health 
in Europe influenced the conceptualisation and conduct 
of this study, including the interviews. Her previous role 
focused on knowledge production for the health sector 
and providing knowledge about the health status of the 
population, influencing factors and how the status can 
be improved. She recognised the need for evidence to 
inform research planning, implementation and evalu-
ation. Therefore, the design and conduct of this study 
were informed by her previous role and influenced the 
development of the interview guide, and interpretation 
and reporting of study findings. Throughout the different 
steps of the study, she consulted a senior researcher (DH) 
to discuss all matters related to the study design, conduct 
and reporting.
Patient and public involvement
Patients and the public were not involved in the design or 
analysis of this study. However, we involved them as study 
participants and will disseminate the study findings that 
4 Nyanchoka L, et al. BMJ Open 2020;10:e039932. doi:10.1136/bmjopen-2020-039932
Open access 
pertain to them using a patient/public online platform, 
peopleinresearch. org.
RESULTS
Among the 30 key stakeholders contacted, 20 agreed to 
participate in the study. Hence, we conducted 20 inter-
views with 20 participants involved in using evidence 
for informing health policy, practice or future research 
(table 1).
Definitions of gaps in health research
We first explored what participants reported as gaps in 
health research. Given the nature of our interest, all 
participants’ answers were grouped under a single theme 
‘Definitions of Gaps in Health Research’. However, the 
focus of the definitions differed, and within this main 
theme, we identified five subthemes related to gaps in 
health research described by the participants (ie, gaps 
in information, knowledge/evidence- related gaps, 
quality of evidence, uncertainties and patient- related 
gaps; summarised in figure 1). The discrepancies and 
similarities of terms used are further illustrated in the 
online supplemental appendix. Terms ranged from 
lack of information/insufficient information, known 
unknowns/unanswered research questions and evidence 
uncertainty to treatment uncertainty, among others.
We identified some similarities among the partici-
pants on how they defined research gaps, for example, 
researchers and oversight bodies mainly defined gaps 
in health research as a lack of information/insufficient 
information, known unknowns and no primary studies 
(more information can be found in online supplemental 
appendix). Patient/public participants defined research 
gaps in a much more literal manner, for example, ‘The 
gap is to get more patients involved in doing … clinical 
trials; have [someone] at the beginning introduce me, 
[educate me], [provide] awareness [because] I didn’t 
know what [a clinical trial] was. I [didn’t] know what 
they’re talking about’ (patient/public person, PPI01) and 
‘Get me involved in co- production. That is the gap that 
is missing in clinical research’ (patient/public person, 
PPI01). The most common description research partici-
pants provided was the absence of scientific information 
to answer a research question, for example,
An area where there is missing or … insufficient in-
formation. And because of this … you cannot reach 
a conclusion for a question. So … it is a field, it is an 
area, a question an issue to which you don’t have an 
appropriate answer because there is missing … infor-
mation or the research that still needs to be done in 
that particular area. (Funding body, F01)
One participant related research gaps to quality of 
evidence by use of Grades of Recommendation, Assess-
ment, Development and Evaluation (GRADE), an 
approach for rating the quality of evidence and grading 
the strength of recommendations in healthcare.21 
Another participant emphasised the importance of 
public and community involvement in gap identification 
to ensure that it takes into account their perspectives and 
contributions to the research ecosystem:
existing knowledge but not documented is of key 
importance in understanding the current body of 
knowledge on a particular topic area …. Evidence 
gaps need to be defined not only by [the] research 
community but also according to the key stakeholders 
including community members. Community knowl-
edge is of key importance to inform the evidence 
base. Further evaluation on research findings to char-
acterise the nature of research gaps can be carried 
out by evaluating community perspectives and local 
evidence to confirm scientific evidence. (Health re-
search PhD student, R01)
We identified variability in participant responses on 
how to define gaps in health research; this variability was 
mainly observed in individual responses for the three 
main categories (research, practice, and policy and 
funding).
Figure 1 Reported descriptions of gaps in health research.
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Methods to identify gaps in health research
Participants reported a range of applicable methods to 
identify gaps in health research (eg, surveys, reviews, 
syntheses, priority- setting partnerships and assessments) 
as shown in figure 2. The methods were also character-
ised by the different research methodologies used (ie, 
primary, secondary and both). Participants also expressed 
their difficulty in identifying research gaps, for example,
It is really difficult to identify research gaps. Lots of 
people you know will try and use the discussion sec-
tion from research, [whereas] other authors have 
asked for further research, but in my experience that 
has not been a very useful method because sometimes 
authors will write that you know without really seeing 
or understanding that there has been something sim-
ilar done in that field. (Health research methodolo-
gist, R02)
The variety of identified methods reflected the state 
of the field in the sense of the wide array of methods 
currently used, in line with the variety of specific goals 
of studies on research gaps (figure 1). The difficulty in 
identifying research gaps raised by participants, together 
with the plurality of definition of gaps and range of meth-
odologies, may, however, also reflect a possible lack of 
consensus and guidance on what method would be best 
suited for a given objective.
Methods to display gaps in health research
Participants referred to a number of different methods 
used to display gaps in health research (ie, forest plots, 
diagrams/illustrations, evidence maps, mega maps, 
3IE gap maps and info graphics) (figure 3). Participant 
perspectives varied; one of the interviewees pointed out,
I think with the growth of technology, it is very import-
ant to use sophisticated methods to better communi-
cate evidence for policy- making and decision- making. 
I think the availability of evidence is not enough on 
its own and finding different methods to communi-
cate is important, not only the analysis and findings 
but also sharing it in different platforms online for a 
greater audience. (Health policy and guideline devel-
oper, P02)
Another participant highlighted that one of the key 
benefits of visually presenting research is being able to 
immediately see what information is available and missing.
The participants mainly expressed the importance of 
using data visualisation in research; there was a common 
understanding on the use of data visualisation as a whole, 
particularly with the growth of technology and the need 
to capitalise on it. The main challenges expressed were 
Figure 2 Methods used to identify gaps in health research.
Figure 3 Methods used to display gaps in health research.
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how to identify an appropriate visualisation to present 
the research and also how to effectively present data. We 
summarise these general experiences with data visualisa-
tion in health research in figure 3 and the online supple-
mental appendix.
DISCUSSION
This study provides insight into issues related to defining, 
identifying and displaying research gaps in health from 
the perspectives of key stakeholders. The findings indi-
cate several definitions of gaps in health research and 
methods used to identify and display research gaps.
Our study confirmed the ambiguity in defining research 
gaps and methodological approaches to identify3 22 
and display research gaps.2 The methods used to iden-
tify research gaps were closely linked to the definition 
of research gaps. For example, the JLA method of gap 
identification and setting priorities for research begins 
by clearly defining what the alliance refers to as evidence 
uncertainty, that is, there is no up- to- date, reliable system-
atic review of research evidence addressing the uncer-
tainty or showing that uncertainty.23 This step further 
informs the rest of the methodology used and is critical 
in identifying treatment uncertainties and determining 
future research priorities. This method combines both 
primary and secondary approaches and not only identi-
fies research gaps but also verifies them across different 
relevant stakeholders, including researchers, patients, 
their carers and clinicians, to ensure the relevance and 
potential benefit to them.23 This verification is important, 
given that some research gaps may be of key interest to 
researchers but have little relevance and importance to 
patients or the public, who should be the main beneficia-
ries of research to improve their health and well- being.
The overall method to identify research gaps involved 
primary, secondary or both approaches (figure 2). Most of 
the participants mentioned the use of secondary research 
methods; this is in accordance with the research that has 
been conducted on research gaps, which has also primarily 
focused on the use of secondary research and developed 
frameworks for identifying research gaps.2 3 8 24 25 The 
most commonly adopted framework involves identifying 
research gaps from systematic reviews using the Popula-
tion, Intervention, Comparison and Outcome framework 
to characterise a research gap.3 The other framework 
involves identifying research gaps in qualitative literature 
reviews.25 In addition, the GRADE approach for rating the 
quality of evidence and grading the strength of recom-
mendations in healthcare21 presents the use of a prom-
inent framework for evaluating the certainty of evidence 
that can inform the research gap and characterise it.26 
Moreover, scoping reviews are commonly used, and the 
definition includes aiming to identify research gaps by 
mapping the current body of evidence. These examples 
focus on the use of secondary research methods, but we 
lack studies that specifically explore the use of primary or 
both primary and secondary methods to identify research 
gaps, yet these methods equally exist and are being used. 
Additional exploration of applicable methods for identi-
fying gaps can improve their usefulness and relevance in 
health research.
In summary, this study showed that research gaps need 
to be defined by researchers and confirmed by different 
research stakeholders such as patients and the public to 
ensure societal relevance and importance.1 We also found 
that clearly defining research gaps can provide information 
on the most appropriate methodological approach to adopt 
in identifying and displaying gaps, for example, for exploring 
research gaps in a specific or broad area. For a specific area, a 
systematic review can be considered, and within a broad area, 
an umbrella review can be considered. The study also showed 
that the use of both primary and secondary methods (JLA 
method) to identify gaps is the most robust method for gap 
identification. The main reported advantage of this method 
is that it identifies gaps (treatment uncertainties) and involves 
different stakeholders, including patients and the public, to 
confirm and prioritise gaps. The main disadvantage is that 
it is labor- intensive (requires a team of different specialists) 
and expensive (administrative support, meeting rooms and 
catering, among others) compared with secondary methods 
(evidence synthesis) or primary methods (survey).
Participants mainly expressed the importance of data visu-
alisation in communicating research; no specific methods or 
formats to present gaps were expressed. Thus, the use of data 
visualisation is desirable among different stakeholders, partic-
ularly researchers, when communicating research, although 
we found few examples of experiences with developing and 
using data visualisation. The participants mainly expressed 
their difficulty in finding the right tool to use to present 
research findings.
Finally, although scientific articles often refer to the exis-
tence of research gaps in studies, few respondents were 
able to define research gaps, unless contextualising them 
within a specific study or area, or methods of identification. 
Fully understanding research gaps in health research and 
adequately addressing them are difficult. In this study, we 
highlighted three key items on the topic: (1) clearly defining 
research gaps provides a context to understand better what 
the gaps are and what they are caused by; (2) a clear defini-
tion of research gaps can inform the methods used to identify 
research gaps, similar to how a clear research question can 
inform the research study methodology; and (3) on adopting 
the most appropriate methods to identify research gaps, 
finding the right visualisation to communicate them effec-
tively is important. Last but not least, public involvement, 
when applicable, is needed to verify that gaps are important 
and relevant to the public.
To conclude, our study found that various methods can be 
used to identify gaps (ie, primary, secondary and both primary 
and secondary). Of all the methods used to identify gaps, 
secondary methods are the most common, specifically system-
atic reviews, which are considered the gold standard in that 
they address a highly focused question related to the existing 
evidence and thus present difficulties for explicitly identi-
fying research gaps in a general area.3 8 27 Other secondary 
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research methods reported were overviews of reviews, also 
known as umbrella reviews, scoping reviews and evidence 
mapping. Overviews of reviews focus on a much broader area, 
compiling evidence from multiple reviews into one accessible 
and usable document and highlighting other reviews within 
the specified topic area.28 29 Given the resource requirements 
of formal evidence reviews, topic prioritisation is needed 
to best allocate resources to those areas deemed the most 
relevant for the health system. Regardless of the topic, the 
prioritisation process is likely to be stakeholder- dependent. 
Priorities for evidence synthesis will vary depending on the 
mission of the healthcare system and the local needs of the 
healthcare stakeholders.1 Hence, using both primary and 
secondary methods is the most robust because it involves 
the participation of patients, caregivers and healthcare and 
social care professionals in identifying research questions and 
then prioritising them using a combination of primary and 
secondary research.30–49
To advance efforts in identifying research gaps, further 
work and different study designs are needed to take this 
work to the next step, to find consensus on definitions and 
different practices for methods in identifying research gaps. 
Subsequently, also assessing the best methods according to 
different stakeholders will be informative and important.
One of the main challenges of this study was that because 
the topic area is still very vague and unclear, the recruitment 
and interview process was challenging. Therefore, this study 
was primarily limited to what participants were familiar with 
and not necessarily representative of the full scope of the status 
of health researchers, health practitioners, oversight bodies 
and patients/public. A more generalisable understanding of 
this topic area would require a larger sample of participants 
and methodology, such as a Delphi survey, and/or a priority- 
setting partnership with representatives using evidence to 
inform policy, practice and research. This study would also 
have benefited from widening the scope of the stakeholder 
categories (use of evidence to inform health policy, health 
practice and health research).2 This would have enriched 
our study findings and provided a wider view of stakeholder 
experiences outside our categories. Another limitation of this 
study is not including patients/public in designing the study. 
Including patient/public perspectives would have benefited 
the study design by being able to improve the importance 
and relevance of the findings for this population.
One of the main strengths of the study is improving the 
definition of research gaps and subsequently improving the 
accurate reporting of research gaps to elucidate the char-
acteristics, which can help in evidence- based decisions. For 
example, a decision based on a research gap contributing 
to lack of primary research on a specific health problem can 
differ from the one based on a research gap related to lack 
of secondary research summarising the research. Hence, all 
these factors regarding research gaps need to be highlighted 
if they are known and made explicit when disseminating 
and communicating research. In addition, providing more 
information on what the gap represents may inform users 
of evidence of more specific information about the research 
gap and how it can be addressed more accurately.
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